Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -1.08x is 73% above its 5-year average of -3.99x, near the high end of its 5-year range (-23.83x–0.57x).
305.59% below its 12-month average of -0.27x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2026 (2026-06-30): 0.57x.
INTEREST COVERAGE RATIO
-1.08x
INTEREST COVERAGE RATIO AVG TTM
-0.27x
INTEREST COVERAGE RATIO AVG 3Y
-3.47x
INTEREST COVERAGE RATIO AVG 5Y
-3.99x
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-305.59%
CURRENT VS 3Y AVG
+68.92%
CURRENT VS 5Y AVG
+72.96%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-6.44x
median of 527 covered companies
CURRENT VS SECTOR MEDIAN
+83.23%
vs the sector median at left
SkinHealth Systems Inc.
Market Cap
$75.95M
Interest Coverage Ratio
-1.08x
TTM Avg
-0.27x
3Y Avg
-3.47x
5Y Avg
-3.99x
Market Cap
$75.18M
Interest Coverage Ratio
-17.01x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$76.74M
Interest Coverage Ratio
-4.78x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$77.54M
Interest Coverage Ratio
-23.23x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$78.07M
Interest Coverage Ratio
N/A
TTM Avg
273.61x
3Y Avg
273.61x
5Y Avg
273.61x
Market Cap
$78.29M
Interest Coverage Ratio
-4056.00x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$78.59M
Interest Coverage Ratio
-5468.00x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$79.03M
Interest Coverage Ratio
-107.89x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| SkinHealth Systems Inc. (SKIN) | $75.95M | -1.08x | -0.27x | -3.47x | -3.99x |
| Pulmonx Corporation (LUNG)vs › | $75.18M | -17.01x | N/A | N/A | N/A |
| Outset Medical, Inc. (OM)vs › | $76.74M | -4.78x | N/A | N/A | N/A |
| Neonc Technologies Holdings, Inc. (NTHI)vs › | $77.54M | -23.23x | N/A | N/A | N/A |
| Inovio Pharmaceuticals, Inc. (INO)vs › | $78.07M | N/A | 273.61x | 273.61x | 273.61x |
| Sera Prognostics, Inc. (SERA)vs › | $78.29M | -4056.00x | N/A | N/A | N/A |
| vTv Therapeutics Inc. (VTVT)vs › | $78.59M | -5468.00x | N/A | N/A | N/A |
| Hyperfine, Inc. (HYPR)vs › | $73.27M | N/A | N/A | N/A | N/A |
| Citius Oncology, Inc. (CTOR)vs › | $79.03M | -107.89x | N/A | N/A | N/A |
| MindWalk Holdings Corp. (HYFT)vs › | $72.83M | N/A | 933.58x | 933.58x | 933.58x |
Interest Coverage
-1.1x
Debt/Equity
6.60
Current Ratio
1.76
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | 0.57x |
| 2026-03-31 | -0.28x |
| 2025-12-31 | 0.03x |
| 2025-09-30 | -0.99x |
| 2025-06-30 | -0.65x |
| 2025-03-31 | -4.81x |
| 2024-12-31 | -2.91x |
| 2024-09-30 | -8.72x |
| 2024-06-30 | -9.02x |
| 2024-03-31 | -5.61x |
| 2023-12-31 | -5.47x |
| 2023-09-30 | -23.83x |
| 2023-06-30 | -3.83x |
| 2023-03-31 | -5.07x |
| 2022-12-31 | -1.11x |
| 2022-09-30 | -1.29x |
| 2022-06-30 | -1.56x |
| 2021-12-31 | -2.07x |
| 2021-09-30 | -10.29x |
| 2021-06-30 | -12.79x |
| 2021-03-31 | 0.42x |
| 2020-12-31 | -0.81x |
| 2020-09-30 | 0.49x |
| 2020-06-30 | -1.40x |
| 2020-03-31 | -1.77x |
